Jim Simons Dynavax Technologies Corp Transaction History
Renaissance Technologies LLC
- $63.4 Billion
- Q4 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Renaissance Technologies LLC holds 2,355,278 shares of DVAX stock, worth $32.1 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
2,355,278
Previous 2,314,278
1.77%
Holding current value
$32.1 Million
Previous $25.8 Million
16.66%
% of portfolio
0.05%
Previous 0.04%
Shares
16 transactions
Others Institutions Holding DVAX
# of Institutions
288Shares Held
131MCall Options Held
507KPut Options Held
374K-
Black Rock Inc. New York, NY21.9MShares$298 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT17.8MShares$242 Million10.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.16MShares$125 Million0.0% of portfolio
-
State Street Corp Boston, MA7.79MShares$106 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ6.56MShares$89.4 Million5.31% of portfolio
About DYNAVAX TECHNOLOGIES CORP
- Ticker DVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 126,474,000
- Market Cap $1.72B
- Description
- Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...